跳至主要内容
临床试验/NCT07026357
NCT07026357已完成不适用

Impact of 3D-planimetry on Optimized Therapeutic Assessment in Complex Benign Esophageal Stenosis; a Prospective Multi-center Study

Thomas Seufferlein1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2022年12月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
22
试验地点
1
主要终点
Endoscopic therapy success

研究概览

简要总结

Esophageal stenosis has a high impact on patients quality of live and food intake affecting personal nutrition status and general health.

For benign strictures of the esophagus, endoscopic dilatation therapy is recommended by actual guidelines.

Since the extent of dilatation is currently directed by endoscopic view and fluoroscopic imaging, patients are exposed to radiation and the determination of the appropriate extent of dilatation is difficult.

Therefore, the aim of this study is to compare the effect of 3D-planimetric measurement with current fluoroscopic monitoring on the success of endoscopic esophageal dilatation therapy in patients with benign esophageal stenosis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •symptomatic benign esophageal stenosis
  • •medical indication for endoscopic therapy
  • •written consent after detailed information

排除标准

  • •non-benign esophageal stenosis
  • •missing written consent
  • •trans-oral endoscopic access is not possible
  • •medical contraindication for endoscopic dilatation therapy
  • •age <18 years

研究组 & 干预措施

Conventional Measurement

Active Comparator

Esophageal stenosis is measured and endoscopic therapy is controlled by fluoroscopy and endoscopic examination only

干预措施: Fluoroscopic control (Radiation)

3D-planimetric Measurement

Experimental

Esophageal stenosis is measured and endoscopic therapy is controlled by 3D-planimetry in addition to the conventional method (fluoroscopy, endoscopic examination)

干预措施: 3D-planimetric measurement (Device)

3D-planimetric Measurement

Experimental

Esophageal stenosis is measured and endoscopic therapy is controlled by 3D-planimetry in addition to the conventional method (fluoroscopy, endoscopic examination)

干预措施: Fluoroscopic control (Radiation)

3D-planimetric Measurement

Experimental

Esophageal stenosis is measured and endoscopic therapy is controlled by 3D-planimetry in addition to the conventional method (fluoroscopy, endoscopic examination)

干预措施: Endoscopic control (Diagnostic Test)

Conventional Measurement

Active Comparator

Esophageal stenosis is measured and endoscopic therapy is controlled by fluoroscopy and endoscopic examination only

干预措施: Endoscopic control (Diagnostic Test)

结局指标

主要结局

Endoscopic therapy success

时间窗: 3 months after intervention at endoscopic control examination

Change in esophageal diameter \[mm\] and length of esophageal stricture \[cm\] after endoscopic therapy

次要结局

  • Length measurement of esophageal stenosis(during endoscopic intervention)
  • Postinterventional esophageal diameter(directly after endoscopic intervention)
  • Hospitalization time after endoscopic dilatation therapy(within 3 months after study intervention)
  • Number of endoscopic interventions(within 3 months after study intervention)
  • Number of hospitalizations due to complications(within 3 months after initial study intervention)
  • Quality of life assessed by German Sydney Swallow Questionnaire(Baseline study intervention and 2 weeks after study intervention)
  • Complication rate(during the procedure)
  • Duration of endoscopic examination(during the procedure)
  • Sedation dose(during the procedure)

研究者

发起方
Thomas Seufferlein
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Thomas Seufferlein

Prof. Dr.

University of Ulm

研究点 (1)

Loading locations...

相似试验